Study Suggests Erectile Dysfunction Meds Linked to Lower Alzheimer's Risk

A study by University College London suggests that men prescribed erectile dysfunction drugs may have an 18% reduced risk of developing Alzheimer's disease. The study surveyed 269,725 men with erectile dysfunction and found that those taking phosphodiesterase type 5 inhibitors had a lower risk of Alzheimer's. However, experts caution that further research and clinical trials are needed to confirm these findings and determine the potential benefits and mechanisms of these drugs in preventing Alzheimer's.